BACKGROUND: The thalidomide disaster resulted in tremendous congenital malformations in more than 10,000 children in the late 1950s and early 1960s. SUMMARY: Although numerous putative mechanisms were proposed to explain thalidomide teratogenicity, it was confirmed only recently that thalidomide, rather its derivative 5-hydroxythalidomide (5HT) in a complex with the cereblon protein, interferes with early embryonic transcriptional regulation. 5HT induces selective degradation of SALL4, a principal transcriptional factor of early embryogenesis. Genetic syndromes caused by pathogenic variants of the SALL4 gene phenocopy thalidomide embryopathy with congenital malformations ranging from phocomelia, reduced radial ray, to defects of the heart, kidneys, ear, eye, and possibly cerebral midline and pituitary. SALL4 interacts with TBX5 and a handful of other transcriptional regulators and downregulates the Sonic hedgehog signaling pathway. Cranial midline defects, microcephaly, and short stature due to growth hormone deficiency have been occasionally reported in children carrying SALL4 pathogenic variants associated with generalized stunting of growth rather than just the loss of height attributable to the shortening of leg bones in many children with thalidomide embryopathy. KEY MESSAGES: Thus, SALL4 joins the candidate gene list for monogenic syndromic pituitary insufficiency. In this review, we summarize the journey from the thalidomide disaster through the functions of the SALL4 gene to its link to the hormonal regulation of growth.

Department of Paediatrics 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czechia

See more in PubMed

Smithells RW, Newman CGH. Recognition of thalidomide defects. J Med Genet. 1992;29(10):716–23. PubMed PMC

Lenz W. A short history of thalidomide embryopathy. Teratology. 1988;38(3):203–15. PubMed

Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140–56. PubMed PMC

Stephens TD, Bunde CJW, Fillmore BJ. Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol. 2000;59(12):1489–99. PubMed

Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, et al. . Identification of a primary target of thalidomide teratogenicity. Science. 2010;327(5971):1345–50. PubMed

Higgins JJ, Pucilowska J, Lombardi RQ, Rooney JP. A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology. 2004;63(10):1927–31. PubMed PMC

Donovan KA, An J, Nowak RP, Yuan JC, Fink EC, Berry BC, et al. . Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome. Elife. 2018;7:e38430–25. PubMed PMC

Kohlhase J, Chitayat D, Kotzot D, Ceylaner S, Froster UG, Fuchs S, et al. . SALL4 mutations in Okihiro syndrome (Duane-radial ray syndrome), acro-renal-ocular syndrome, and related disorders. Hum Mutat. 2005;26(3):176–83. PubMed

Elling U, Klasen C, Eisenberger T, Anlag K, Treier M. Murine inner cell mass-derived lineages depend on Sall4 function. Proc Natl Acad Sci USA. 2006;103(44):16319–24. PubMed PMC

Sakaki-Yumoto M, Kobayashi C, Sato A, Fujimura S, Matsumoto Y, Takasato M, et al. . The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development. Development. 2006;133(15):3005–13. PubMed

Tatetsu H, Kong NR, Chong G, Amabile G, Tenen DG, Chai L. SALL4, the missing link between stem cells, development and cancer. Gene. 2016;584(2):111–9. PubMed PMC

Koshiba-Takeuchi K, Takeuchi JK, Arruda EP, Kathiriya IS, Mo R, Hui CC, et al. . Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart. Nat Genet. 2006;38(2):175–83. PubMed

Kohlhase J, Heinrich M, Liebers M, Fröhlich Archangelo L, Reardon W, Kispert A. Cloning and expression analysis of Sall4, the murine homologue of the gene mutated in Okihiro syndrome. Cytogenet Genome Res. 2002;98(4):274–7. PubMed

Furihata H, Yamanaka S, Honda T, Miyauchi Y, Asano A, Shibata N, et al. . Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide. Nat Commun. 2020;11(1):4578–11. PubMed PMC

Matyskiela ME, Couto S, Zheng X, Lu G, Hui J, Stamp K, et al. . SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Nat Chem Biol. 2018;14(10):981–7. PubMed

Yamanaka S, Murai H, Saito D, Abe G, Tokunaga E, Iwasaki T, et al. . Thalidomide and its metabolite 5‐hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF. EMBO J. 2021;40(4):e105375–25. PubMed PMC

Asatsuma-Okumura T, Ando H, De Simone M, Yamamoto J, Sato T, Shimizu N, et al. . p63 is a cereblon substrate involved in thalidomide teratogenicity. Nat Chem Biol. 2019;15(11):1077–84. PubMed

Akiyama R, Kawakami H, Wong J, Oishi I, Nishinakamura R, Kawakami Y. Sall4-Gli3 system in early limb progenitors is essential for the development of limb skeletal elements. Proc Natl Acad Sci USA. 2015;112(16):5075–80. PubMed PMC

Kohlhase J, Heinrich M, Schubert L, Liebers M, Kispert A, Laccone F, et al. . Okihiro syndrome is caused by SALL4 mutations. Hum Mol Genet. 2002;11(23):2979–87. PubMed

Kowalski TW, Caldas-Garcia GB, Gomes Jd A, Fraga LR, Schuler-Faccini L, Recamonde-Mendoza M, et al. . Comparative genomics identifies putative interspecies mechanisms underlying Crbn-Sall4-linked thalidomide embryopathy. Front Genet. 2021;12:680217–1. PubMed PMC

Cui W, Kong NR, Ma Y, Amin HM, Lai R, Chai L. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Mod Pathol. 2006;19(12):1585–92. PubMed

Yang J. SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis. Biomark Res. 2018;6(1):1–9. PubMed PMC

Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, et al. . Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci USA. 2008;105(50):19756–61. PubMed PMC

Lim CY, Tam W, Zhang J, Ang HS, Jia H, Lipovich L, et al. . Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell. 2008;3(5):543–54. PubMed

Wu Q, Chen X, Zhang J, Loh Y, Low T, Zhang W, et al. . Sall4 interacts with Nanog and Co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem. 2006;281(34):24090–4. PubMed

Latos PA, Hemberger M. From the stem of the placental tree: trophoblast stem cells and their progeny. Development. 2016;143(20):3650–60. PubMed

Young JJ, Kjolby RAS, Kong NR, Monica SD, Harland RM. Spalt-like 4 promotes posterior neural fates via repression of pou5f3 family members in Xenopus. Development. 2014;141(8):1683–93. PubMed PMC

Ng JK, Kawakami Y, Büscher D, Raya Á, Itoh T, Koth CM, et al. . The limb identity gene Tbx5 promotes limb initiation by interacting with Wnt2b and Fgf10. Development. 2002;129(22):5161–70. PubMed

Smith Genes JTB. What they do and how they do it. Trends Genet. 1999;15(4):33–5.

Papaioannou VE. T-box genes in development: from hydra to humans. Int Rev Cytol. 2001;207:1–70. PubMed

Al-Baradie R, Yamada K, St Hilaire C, Chan WM, Andrews C, McIntosh N, et al. . Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet. 2002;71(5):1195–9. PubMed PMC

Zhang L, Mubarak T, Chen Y, Lee T, Pollock A, Sun T. Counter-balance between Gli3 and miR-7 is required for proper morphogenesis and size control of the mouse brain. Front Cell Neurosci. 2018;12:259–14. PubMed PMC

Kelberman D, Dattani MT. Genetics of septo-optic dysplasia. Pituitary. 2007;10(4):393–407. PubMed

Chun B, Mazzoli R, Raymond W. Characteristics of Okihiro syndrome. J Pediatr Ophthalmol Strabismus. 2001;38(4):235–9. PubMed

Newbury-Ecob R, Leanage R, Raeburn J, Young I. Holt-Oram syndrome: a clinical genetic study. J Med Genet. 1996;33(4):300–7. PubMed PMC

Brassington A-ME, Sung SS, Toydemir RM, Le T, Roeder AD, Rutherford AE, et al. . Expressivity of holt-oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet. 2003;73(1):74–85. PubMed PMC

Miertus J, Borozdin W, Frecer V, Tonini G, Bertok S, Amoroso A, et al. . A SALL4 zinc finger missense mutation predicted to result in increased DNA binding affinity is associated with cranial midline defects and mild features of Okihiro syndrome. Hum Genet. 2006;119(1–2):154–61. PubMed

Halal F, Homsy M, Perreault G. Acro-renal-ocular syndrome: autosomal dominant thumb hypoplasia, renal ectopia, and eye defect. Am J Med Genet. 1984;17(4):753–62. PubMed

Takeuchi JK, Koshiba-Takeuchi K, Matsumoto K, Vogel-Höpker A, Naitoh-Matsuo M, Ogura K, et al. . Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds. Nature. 1999;398(6730):810–4. PubMed

Laufer E, Dahn R, Orozco O, Yeo C, Pisenti J, Henrique D, et al. . Expression of Radical fringe in limb-bud ectoderm regulates apical ectodermal ridge formation. Nature. 1997;386(6623):366–73. PubMed

Riddle R, Johnson RL, Laufer E, Tabin C. Sonic hedgehog mediates the polarizing activity of the ZPA. Cell. 1993;75(7):1401–16. PubMed

Oberg K, Feenstra J, Manske P, Tonkin M. Developmental biology and classification of congenital anomalies of the hand and upper extremity. J Hand Surg. 2010;35(12):2066–76. PubMed

Kodytková A, Amaratunga SA, Zemková D, Maratová K, Dušátková P, Plachý L, et al. . SALL4 phenotype in a 4-generational family: an interplay of the upper limb, renal development and pituitary function. Horm Res Paediatr. 2022. PubMed